Company / Total Assets
Bio-Techne Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$2.6B
FY2025
5-year range
$2.3B / $2.7B
FY2021-FY2025
Trend
-5.4%
vs FY2024
Sector context
#84 of 161
Health Care
What the data says
At $2.6B, Bio-Techne's total assets ranks #84 of 161 in the Health Care sector. Declined from $2.6B to $2.6B over the past 2 years.
Based on SEC 10-K filings.
$2.6B in FY2025 with a 5-year CAGR of +4.8%.
Declined from $2.6B to $2.6B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +3.7%
- 5-Year CAGR
- +4.8%
- 10-Year CAGR
- -
Sector benchmark
#84 of 161 in Health CareTop 52% of 161This company $2.6B Sector average $14.8B
▼
-82.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.8%, indicating consistent growth.
- In FY2025, total assets decreased 5.4% year-over-year.
- Ranks #84 out of 161 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.6B | -5.4% |
| FY2024 | $2.7B | +2.5% |
| FY2023 | $2.6B | +15.0% |
| FY2022 | $2.3B | +1.4% |
| FY2021 | $2.3B | +11.6% |
| FY2020 | $2.0B | +7.6% |
| FY2019 | $1.9B | +18.3% |
| FY2018 | $1.6B | +2.2% |
| FY2017 | $1.6B | +37.9% |
| FY2016 | $1.1B | +6.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026